Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors
Nurse-led and GP-supported Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors With Cardiovascular Diseases
1 other identifier
interventional
15
1 country
3
Brief Summary
The goal of this proposed single-group pre-post pilot study is to assess the feasibility and acceptability of the codesigned Nurse-led and GP-supported self-management interventions (NGPS) to reduce cardiovascular risks in breast cancer survivors with cardiovascular diseases. The study will also assess the preliminary effects of the NGPS intervention on various outcomes, such as behavioural, physiological, psychological, and healthcare usage. These outcomes will be measured at three time points, which include the baseline measurement at recruitment (T1-week 1), right after the four weeks' intervention (T2-week 4), and eight weeks after completing the intervention (T3-week 12). The study will be conducted in the primary care centres, and the self-management interventions are behavioural change interventions such as physical activity, diet modifications, tobacco cessation, weight management, eliminating or reducing alcohol consumption, and mind-body exercises such as yoga. The main questions it aims to answer are:
- 1.What are the recruitment, retention, attrition, and completion rates of participants and potential adverse effects related to the NGPS interventions for the participants throughout the pilot study?
- 2.What are the adherence rates of the NGPS protocol, participants' response and completion rates of the study instruments during the data collection period of the pilot study?
- 3.Do this pilot study results indicate any significant differences in cardiovascular health outcomes (e.g., BMI and blood pressure), physical activity, dietary intake, QoL, self-efficacy, anxiety and depression between and across different time points (Baseline (T1), post-intervention (T2), follow-up (T3))?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Mar 2026
Shorter than P25 for not_applicable breast-cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2025
CompletedFirst Posted
Study publicly available on registry
December 31, 2025
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
January 8, 2026
January 1, 2026
9 months
November 13, 2025
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Baseline Information
Collect socio-demographic characteristics of the breast cancer survivors such as age, height, race/ethinicity, religion, education level, marital status, employment status and annual household income as well as medical history
Once at baseline
Feasibility of recruitment
Number of weeks/months needed to reach target sample size
From recruitment start (Day 1 of the recruitment) to recruitment close (the day that the target sample reached), up to 12 months
Recruitment rate
The percentage of eligible (or approached) participants who actually agree to take part in the study.
Recruitment rate will be assessed monthly over the recruitment period (up to 12 months).
Retention rate
The percentage of participants who remain in the study
Across the entire trial period, from enrolment to eight weeks post study follow-up
Dropout rate
The percentage of participants dropped out after the study enrolment
Across the entire trial period, from enrolment to eight weeks post study follow-up
Feasibility of the questionnaires
The percentage of missing responses for each item and the entire scale in each questionnaires
Across the entire trial period, from enrolment to eight weeks post study follow-up
Feasibility and acceptability of the study intervention- Adherence rate
The percentage of participants who followed the prescribed interventions as intended
From week one to week four, during the intervention period
Safety of the intervention- Adverse Events related to the Nurse-led and GP-supported self-management (NGPS) intervention
Asking the participants to record any discomfort feelings or adverse events related to the NGPS intervention, keeping daily logbook and report via telephone or face-to-face
From week one to week four, during the intervention period
Acceptability of the intervention
Feedback on the NGPS program will be gained by using an investigator-created questionnaire. Participants are asked to specify the extent to which they agree with each statement about the intervention by selecting one response option that best indicates their views. The numeric value will range from 1 to 5, where 1 indicates strongly disagree, 2 indicates disagree, 3 indicates neither agree nor disagree, 4 indicates agree, and 5 indicates strongly agree. The minimum value is 1, and the maximum score is 5. Higher scores indicate greater acceptability of the intervention and a better outcome.
At eight-week follow up
Secondary Outcomes (10)
Physiological outcomes- BMI
At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)
Physiological outcomes-blood pressure
At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)
Physiological outcomes-heart rate
At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)
Behavioural outcomes using 15-item food frequency questionnaire
At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)
Behavioural outcomes- Self-reported smoking status
At baseline (T1), immediately post intervention (T2), and eight-week follow-up (T3)
- +5 more secondary outcomes
Study Arms (1)
Self-management intervention group
EXPERIMENTALA combined face-to-face and telehealth self-management intervention will be conducted over four weeks, following assessment of the patients' cardiac condition, breast cancer, health literacy, and access to resources. The interventions will be carried out mainly by nurses, GPs, and allied health professionals, who will be included if needed. Patients and caregivers will be involved in the sessions. The self-management interventions will be behaviour change interventions, such as physical exercise, dietary modifications, smoking cessation and weight management.
Interventions
Self-management interventions will cover physical activity, smoking cessation, weight management, diet modifications, eliminate or reduce alcohol consumption and mind-body exercise such as taichi, yoga.
Eligibility Criteria
You may qualify if:
- aged 18 years or older
- confirmed diagnosis of breast cancer at stage I, II, or IIIa
- confirmed diagnosis of CVDs, including heart failure, coronary artery disease, stroke, or transient ischemic attack
- able to read, write, and communicate in English
- have completed active anticancer treatment including chemotherapy and radiotherapy, and are receiving regular healthcare in a primary care centre from GP/practice nurses and are willing to participate in the research study and provide informed consent.
You may not qualify if:
- patients with unstable health conditions with mental health issues or critically ill patients unable to participate in physical activities (e.g., suffering from life-threatening diseases, extremely weak), cognitive impairment, currently involved in another research study, or scheduled anticancer treatment during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Greens Medical Group, Dandenong South
Melbourne, Victoria, 3173, Australia
Keys Medical Centre, Keysborough
Melbourne, Victoria, 3173, Australia
TLC Medical Clinic, Noble Park
Melbourne, Victoria, 3173, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alison Wang, PhD
University of Southern Queensland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 13, 2025
First Posted
December 31, 2025
Study Start
March 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share